Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
1.828
-0.073 (-3.82%)
Aug 5, 2026, 12:34 PM EDT - Market open
Silexion Therapeutics Market Cap
Silexion Therapeutics has a market cap or net worth of $765.71 thousand as of August 5, 2026. Its market cap has decreased by -85.38% in one year.
Market Cap
765.71K
Enterprise Value
372.09K
1-Year Change
-85.38%
Ranking
Category
Stock Price
$1.83
ChartMarket Cap Chart
Since April 7, 2021, Silexion Therapeutics's market cap has decreased from $148.54M to $765.71K, a decrease of -99.48%. That is a compound annual growth rate of -62.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 765.71K | -87.24% |
| Dec 31, 2025 | 6.00M | 86.31% |
| Dec 31, 2024 | 3.22M | -92.32% |
| Dec 21, 2023 | 41.98M | -71.93% |
| Dec 30, 2022 | 149.58M | 4.03% |
| Dec 31, 2021 | 143.79M | -3.20% |
| Apr 7, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Calidi Biotherapeutics | 2.17M |
| Moleculin Biotech | 2.11M |
| CDT Equity | 2.02M |
| Genprex | 2.02M |
| Matinas BioPharma Holdings | 1.88M |
| Bone Biologics | 1.76M |
| VivoSim Labs | 1.22M |
| Biodexa Pharmaceuticals | 1.21M |